Benzinga | Aug 10, 2020 07:42AM EDT

Paratek Pharmaceuticals Q2 EPS $(0.53) May Not Compare To $(0.06) Estimate, Sales $9.30M May Not Compare To $38.03M Estimate

Paratek Pharmaceuticals (NASDAQ:PRTK) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.06) by 783.33 percent. This is a 48.04 percent increase over losses of $(1.02) per share from the same period last year. The company reported quarterly sales of $9.30 million which missed the analyst consensus estimate of $38.03 million by 75.55 percent. This is a 354.77 percent increase over sales of $2.04 million the same period last year.